Prophylaxis of AIDS-related opportunistic infections (OIs).
Hardy
W D
WD
School of Medicine, University of California-Los Angeles.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D003453:Cryptococcosis / Q000150:complications / Q000517:prevention & control; D003586:Cytomegalovirus Infections / Q000150:complications / Q000517:prevention & control; D003622:Dapsone / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D009894:Opportunistic Infections / Q000150:complications / Q000517:prevention & control*; D010419:Pentamidine / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000517:prevention & control; D011739:Pyrimethamine / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000150:complications / Q000517:prevention & control; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D013413:Sulfadoxine; D003622:Dapsone; D011739:Pyrimethamine